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Neurofibromatosis type 1(NF-1) is the most common
neurocutaneous syndrome with multisystemic involve-
ment of skin, nervous system, bones, endocrine glands
and sometimes other organs at various sites, occurs in
one of every 2,000~3,000 live births (1). It is a genetic
disorder, caused by a mutation in the NF-1 gene on
chromosome 17 (1). The most frequently encountered
clinical findings include cafe au lait spots, freckling,
neurofibromas (dermal and plexiform), optic nerve
gliomas, Lisch nodules, learning disabilities and
skeletal abnormalities (scoliosis and pseudoarthrosis)
(2). Central nervous system manifestations of neurofi-
bromatosis were also reported, including cranial nerve
schwannomas, meningiomas, pilocytic astrocytomas,
gliomas, ependymomas, angiomas and hamartomatous
lesions (3). NF-1 vasculopathy is a significant but
under-recognized complication of the disease. The
neurovascular abnormality in NF-1 patients can be
various, including intraarterial occlusive disease, arteri-
ovenous fistula, aneurysm formation of the intracranial,
extracranial carotid or vertebral arteries (4).
We report here a case of neurovascular involvement
in NF-1 patient as a form of multifocal intra and
extracranial aneurysms.
CASE REPORT
A 16-year-old boy had suffered from visual distur-
bance for about 1 year, presenting as dots and lines on
the visual field of 30 minutes’ duration in a month or
two. He had a history of multiple surgical excision of
neurofibromas from various sites by birth, and had
suffered from mild right side weakness and lower
extremity hemihypertrophy for a long time. He also
had been afflicted with osseous abnormalities, such as
anterolateral bowing of tibia, hypoplasia of fibula,
diffuse enchondromatosis and osteoporosis of lower
extremities which can be considered as musculoskele-
tal involvement of NF-1.
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Neurofibromatosis type 1 (NF-1) has a variety of localized or systemic manifestations. Among them,
Cerebrovascular dysplasia can be very rare finding of neurofibromatosis which can be very rarely seen.
Here we report a case of 17-year-old boy representing bilateral giant fusiform aneurysms of extracranial
internal carotid arteries and intracranial aneurysms of left middle cerebral artery. He showed no related
symptoms at all, but screening for vascular lesions and close monitoring is warranted in NF-1 patients
considering that it can be symptomatic unexpectedly.
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neurologic dysfunction, except for mild right side
weakness, has long been presented. The brain CT
showed the porencephalic changes of the left cerebral
hemisphere, which might be confused for unilateral
hydrocephalus.
The patient was referred to our medical center for
further evaluation. MR imaging demonstrated the
porencephalic change of the left cerebral hemisphere
with arachnoid cyst along left anterior temporal
convexity (Fig. 1A). Focal ovoid shaped signal void at
the inferior aspect of left temporal lobe showed
continuity with M1 segment of left middle cerebral
artery (MCA), suggesting focal aneurysmal dilation of
left MCA. There was no infarction or other vascular
malformation.
Conventional angiography revealed bilateral
strikingly large-sized, fusiform aneurysms arising from
extracranial internal carotid arteries. We also found
other smaller fusiform aneurysms of proximal M1
segment and bifurcation area of left MCA. There were
no abnormal findings of the vertebrobasilar arterial
system (Fig. 1B, C and D).
The patient discharged without any targeted therapy
for the incidentally founded aneurysms. As it was too
large and extensive to apply interventional treatment
and considering the fragility of aneurysmal vascular
wall, the procedure would be very risky. Instead we
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Fig. 1. A. T2-weighted image of the
patient’s brain MRI shows porencephalic
change of left cerebral hemisphere
shows some cavitation suspiciously
communicating with left lateral ventricle. 
B. Angiography of the right ICA reveals
large fusiform aneurysm arising from
proximal ICA. The continuous draining
artery shows marked tortuous dilation.
The aneurysmal filling is not complete
enough for the precise deliniation of
whole contour of aneurysm. 
C. Angiography of the left ICA reveals
another giant fusiform aneurysm arising
from the similar location to right side.
D. Intracranial view of left ICA angiogra-
phy  shows  two  more  intracranial
fusiform aneurysms (arrows) arising
from proximal M1 segment and MCA
bifurcation.decided to monitor the patient’s status carefully.
DISCUSSION
NF-1 vasculopathy is a potentially serious but less
well-known, under-recognized component of this
multisystemic, genetic disorder. Recent research on the
morbidity and mortality in NF-1 disclosed 2 factors
independently associated with an excess of mortality in
children and adults under 30 years of age, soft tissue
malignancies and vascular disease (5).
Various vascular lesions of NF-1 have been noted in
patients with NF-1, and are characterized by stenosis,
rupture and aneurysm or fistula formation of large and
medium-sized arteries. Although the arterial system is
most commonly affected, venous circulation may also
be involved (2). Overall, the most common manifesta-
tion of NF-1 vasculopathy is renal artery dysplasia, and
hypertension is the usual manifestation. The most
common form of cerebral vasculopathy in NF-1
patients is intracranial arterial occlusive disease,
usually occurring in childhood or adolescence and
often associated with a moya-moya pattern of collateral
blood flow (4).
The precise mechanism involved in cerebral
vasculopathy in NF-1 is still not well understood but
are likely related to the function of neurofibromin, the
protein  product  of  the  NF-1  gene  (2,  5,  6).
Neurofibromin has been shown to control cell growth
by positively regulating intracellular level of cAMP
and negatively regulating Ras signaling pathway (6).
Loss of neurofibromin expression seen in NF-1
increases the proliferation of vascular smooth muscle
cells  through  the  RAS  signaling  system  with
subsequent intimal proliferation and arterial stenosis. It
has also been shown that there is a different distribution
of neurofibromin within the endothelial and smooth
muscle layers in different vessels, which is thought to
explain why the renal and cerebral vessels are more
commonly affected than the aorta by vascular dysplasia
in NF-1 (7).
The cerebral vascular lesions seen in NF-1 can be
divided into three groups: stenotic lesions, aneurysmal
lesion or both stenotic and aneurysmal lesion. In the
reported cases, stenotic lesions occur in 71% of
patients, aneurysmal lesions in 19% and both lesions in
10%. Children usually had stenotic lesions (89%), with
the remaining being aneurysms only. Adults were also
more likely to have stenotic lesions (39%), with
aneurysm in 35% and both lesions in 26% (7). Our
patient showed only aneurysmal lesions without
definite stenotic lesion. Ku et al. (5) reported a case of
28-year-old woman, had bilateral giant extracranial
aneurysms of the internal carotid arteries, which shows
very similar manifestation of cerebral vasculopathy in
NF-1 to our patient. In comparison with our case of
relatively asymptomatic 17-year-old boy, the patient
developed sudden-onset symptoms related to her
vascular lesions followed by prompt coil embolization
and graft stent placement of the affected arteries. And
the aneurysms were surrounded by plexiform neurofi-
bromas, suggesting the compression and/or infiltration
by mass may have been affected the vascular wall
weakening to some degree. In our case, there showed
no definite relationship between neurofibromas and
bilateral extracranial fusiform aneurysms. And there
were other intracranial MCA aneurysms, apart from
any suspected neurofibromas.
On review of the literature, the internal carotid artery
was most commonly affected (44%) followed by the
middle cerebral artery (19.3%), the anterior cerebral
artery (16.4%) and the posterior cerebral artery (8.2%).
This data shows concordance with our case, which
affected both internal carotid arteries and left middle
cerebral artery (7). Schievink et al. (4) reported a study
suggesting that patients with NF-1 are at an increased
risk of developing intracranial aneurysms. According
to this article, the most common neurovascular
abnormality in NF-1 patients is intracranial arterial
occlusive disease, and other neurovascular manifesta-
tions of NF-1 include arteriovenous fistula and
aneurysm formation of the extracranial carotid or
vertebral arteries.
Although our patient was asymptomatic for his
neurovascular lesions, many reports recommend
detailed imaging of patients with NF-1 to clarify
vascular structure and blood flow patterns and close
monitoring of any neurovascular abnormalities
(2,4,5,7). Because the long-term outcome of those
vascular lesions has not been clearly revealed and the
most vascular lesions are asymptomatic at diagnosis
but can present with sudden-out symptoms. Previous
reports of intracranial aneurysms in patients with NF-1
have shown that the aneurysms may be saccular or
fusiform, the latter probably resulting from sponta-
neous arterial dissection. and screening for intracranial
aneurysms generally is recommended for at-risk
populations because the outcome of aneurysmal
subarachnoid hemorrhage is poor and treatment for
most unruptured aneurysms can be accomplished
safely (4).
With the knowledge of cerebrovascular dysplastic
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lesions as significant but under-recognized complica-
tions of patients in NF-1, the careful and detailed
imaging surveillance with a low threshold for
angiographic investigations is recommended indepen-
dent of the presence of symptom.
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